相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development
Lingli Zhou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGF beta-Induced Breast Cancer Metastasis
Sijia Liu et al.
CLINICAL CANCER RESEARCH (2020)
USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ
Hong Zhu et al.
CANCER RESEARCH (2020)
Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia
Qian Qian Wang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2019)
Breaking the chains: deubiquitylating enzyme specificity begets function
Michael J. Clague et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia
Maurizio Gianni et al.
ONCOGENE (2019)
Receptor Tyrosine Kinase Fusions as an Actionable Resistance Mechanism to EGFR TKIs in EGFR-Mutant Non-Small-Cell Lung Cancer
Viola W. Zhu et al.
TRENDS IN CANCER (2019)
Deubiquitylating enzymes and drug discovery: emerging opportunities
Jeanine A. Harrigan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
Meidan Ying et al.
BLOOD (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway
Zhen-Hua Chen et al.
CELL DEATH AND DIFFERENTIATION (2017)
VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy
Chrisovalantis Papadopoulos et al.
EMBO JOURNAL (2017)
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
Lisa Maria Mustachio et al.
MOLECULAR CANCER RESEARCH (2017)
Inhibition of USP10 induces degradation of oncogenic FLT3
Ellen L. Weisberg et al.
NATURE CHEMICAL BIOLOGY (2017)
Targeting TRK family proteins in cancer
Yekaterina B. Khotskaya et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability
Youngeun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program
Ryan Tasseff et al.
SCIENTIFIC REPORTS (2017)
Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
Hugues de The et al.
CANCER CELL (2017)
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence
Ke Li et al.
CANCER CELL (2017)
Varying responses of PML-RARA with different genetic mutations to arsenic trioxide
Jiangying Liu et al.
BLOOD (2016)
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V. Madan et al.
LEUKEMIA (2016)
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Omid Tavana et al.
NATURE MEDICINE (2016)
Microenvironmental Remodeling as a Parameter and Prognostic Factor of Heterogeneous Leukemogenesis in Acute Myelogenous Leukemia
Jin-A Kim et al.
CANCER RESEARCH (2015)
MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia
Cheng-Wu Zeng et al.
AUTOPHAGY (2014)
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
Saar Gill et al.
BLOOD (2014)
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Qiang Zou et al.
NATURE IMMUNOLOGY (2014)
A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation
Sharvan Sehrawat et al.
BLOOD (2013)
PML-RARα and Its Phosphorylation Regulate PML Oligomerization and HIPK2 Stability
Yutaka Shima et al.
CANCER RESEARCH (2013)
OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis
Tycho E. T. Mevissen et al.
CELL (2013)
Molecular Pathways: ROS1 Fusion Proteins in Cancer
Kurtis D. Davies et al.
CLINICAL CANCER RESEARCH (2013)
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Benedicte F. Py et al.
MOLECULAR CELL (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability
W-C Yang et al.
ONCOGENE (2013)
Curing APL through PML/RARA degradation by As2O3
Valerie Lallemand-Breitenbach et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment
Emi Goto et al.
BLOOD (2011)
Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
Pauline Isakson et al.
BLOOD (2010)
Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma
Hayriye V. Erkizan et al.
CLINICAL CANCER RESEARCH (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB
Alessandra Fontanini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Otubain YOD1 Is a Deubiquitinating Enzyme that Associates with p97 to Facilitate Protein Dislocation from the ER
Robert Ernst et al.
MOLECULAR CELL (2009)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Rihab Nasr et al.
NATURE MEDICINE (2008)
The ubiquitin-specific protease USP28 is required for MYC stability
Nikita Popov et al.
NATURE CELL BIOLOGY (2007)
Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential
A. M. S. Cheung et al.
LEUKEMIA (2007)
Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis
Emanuela Aleo et al.
CANCER RESEARCH (2006)
Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen
C Girmenia et al.
LEUKEMIA (2003)
Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25α-dihydroxyvitamin D3 or All-trans-retinoic acid
MT Drayson et al.
EXPERIMENTAL CELL RESEARCH (2001)
分享论文
